Trials / Completed
CompletedNCT00712686
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
A Multicenter, Double-Blind, Randomized, Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 690 (actual)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and tolerability of aripiprazole to olanzapine over 26 weeks for the treatment of schizophrenia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole | Tablets, Oral, 15-30 mg, once daily, 140 weeks |
| DRUG | Olanzapine | Capsule, Oral, 10-20 mg, once daily, 140 weeks |
Timeline
- Start date
- 2000-06-01
- Primary completion
- 2003-12-01
- Completion
- 2003-12-01
- First posted
- 2008-07-10
- Last updated
- 2013-11-08
Source: ClinicalTrials.gov record NCT00712686. Inclusion in this directory is not an endorsement.